References
- Buckpitt A. R., Castagnoli N., Jr, Nelson S. D., Jones A. D., Bahnson L. S. Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes. Drug Metabolism and Disposition 1987; 15: 491–498
- Daly J. W., Jerina D. M., Witkop B. Arene oxides and NIH shift: the metabolism, toxicity and carcinogenicity of aromatic hydrocarbons. Experientia 1972; 28: 1129–1149
- Hanada K., Tamai M., Morimoto S., Adachi T., Oguma K., Ohmura S., Ohzeki M. A specific thiol protease inhibitor, E‐64 and its derivatives. Peptide Chemistry 1979; 1979: 31–36
- Hashida S., Towatari T., Kominami E., Katsunuma N. Inhibitions by E‐64 dervatives of rat liver cathepsin B and L in vitro and in vivo. Journal of Biochemistry (Tokyo) 1980; 88: 1805–1811
- Hernandez O., Bend J. R. Metabolism of epoxides. Metabolic Basis of Detoxication, W. B. Jakoby, J. R. Bend, J. Caldwell. Academic Press, New York 1982; 207–233
- Hudecki M. S., Pollina C. M., Heffner R. R. Limited benefit to genetically dystrophic chickens from a synthetic proteinase inhibitor, Ep475. Journal of the Neurological Sciences 1983; 60: 55–66
- Jasmin G., Proschek L. Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster. Canadian Journal of Physiological Pharmacology 1984; 62: 891–898
- Kar N. C., Pearson C. M. Muscular dystrophy and activation of proteinases. Muscle and Nerve 1978; 1: 308–313
- Kimura M., Yagi K., Fujimura S., Tsuchida T., Tarumoto Y., Noda K., Nakane S. Toxicological studies on ethyl‐(+)‐(2S,3S)‐3‐‘(S)‐3‐methyl‐1‐)3‐methylbutylcarbamoyl)‐ butylcarbamoyl’‐2‐oxiranecarboxylate (EST) III: Subacute toxicity in rats. Iyakuhin Kenkyu 1986; 17: 744–767
- Moss E. J., Judah D. J., Przybylski M., Neal G. E. Some mass‐spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1. Biochemical Journal 1983; 210: 227–233
- Smith D. A., Johnson P. M., Wilkinson D. J. Conjugation of disodium 6‐chloro‐4‐oxo‐10‐propyl‐4H‐pyrano‐3,2g quinoline‐2,8‐dicarboxylate with glutathione in the rat. Xenobiotica 1985; 15: 437–444
- Suzuki K. Reaction of calcium‐activated neutral protease(CANP) with an epoxisuccinyl derivative (E‐64‐c) and iodoacetic acid. Journal of Biochemistry (Tokyo) 1983; 93: 1305–1312
- Tamai M., Matsumoto K., Ohmura S., Koyama I., Ozawa Y., Hanada K. Invitro and in vivo inhibition of cysteine proteases by EST, a new analogue of E‐64. Journal of Pharmacobio‐Dynamics 1986; 9: 672–677
- Tamai M., Yokoo C., Murata M., Oguma K., Sato K., Kominami Y. Efficient synthetic method for ethyl(+)‐(2S,3S)‐3‐‘(S)‐3‐methyl‐1‐(3‐methylbutylcarbamoyl)‐butylcarbamoyl’‐2‐oxiranecarboxylate (EST), a new inhibitor of cysteine protease. Chemical and Pharmaceutical Bulletin 1987a; 35: 1098–1104
- Tamai M., Ohmura S., Kimura M., Hanada K., Sugita H. Prolongation of life span of dystrophic hamster by cysteine protease inhibitor, loxistain (EST). Journal of Pharmacobio‐Dynamics 1987b; 10: 678–681
- te Koppele J. M., van der Mark E. J., Olde Boerrigter J. C., Brussee J., van der Gen A., van der Greef J., Mulder G. J. α‐Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat. I. (Bio‐)synthesis, analysis and identification of diastereomeric glutathione conjugates and mercapturates. Journal of Pharmacology and Experimental Therapeutics 1986; 239: 898–904
- Watabe T., Hiratsuka A., Ishikawa K., Isobe M., Ozawa N. 7‐Glycidoxycoumarin (GOC): a fluorophotometric epoxide substrate for the assay of glutathione S‐transferase activity. Biochemical Pharmacology 1984; 33: 1839–1844